wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33841419-DF65F0D1-C61B-4B58-9A3D-E6872EA12576
Q33841419-DF65F0D1-C61B-4B58-9A3D-E6872EA12576
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33841419-DF65F0D1-C61B-4B58-9A3D-E6872EA12576
Future therapeutic targets in rheumatoid arthritis?
P2860
Q33841419-DF65F0D1-C61B-4B58-9A3D-E6872EA12576
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33841419-DF65F0D1-C61B-4B58-9A3D-E6872EA12576
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f47b17ef8355624635af8f8c260a51d47f2dc397
P2860
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.